External Beam Radiotherapy Alone in Advanced Esophageal Cancer.
- Author:
Sung Ja AHN
;
Woong Ki CHUNG
;
Byung Sik NAH
;
Taek Keun NAM
- Publication Type:Original Article
- Keywords:
External beam radiotherapy;
Advanced esophageal cancer
- MeSH:
Brachytherapy;
Carcinoma, Squamous Cell;
Deglutition Disorders;
Diet;
Drug Therapy;
Esophageal Neoplasms*;
Esophagus;
Female;
Follow-Up Studies;
Gastrostomy;
Humans;
Lymphatic Diseases;
Male;
Middle Aged;
Multivariate Analysis;
Radiotherapy*;
Retrospective Studies;
Survival Rate;
Thorax;
Tomography, X-Ray Computed;
Treatment Outcome
- From:The Journal of the Korean Society for Therapeutic Radiology and Oncology
2000;18(1):11-16
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We performed the retrospective analysis to find the outcome of external beam radiotherapy alone in advanced esophageal cancer patients. METHODS AND MATERIALS: One hundred and six patients treated with external beam radiotherapy alone between July 1990 and December 1996 were analyzed retrospectively. We limited the site of the lesions to the thoracic esophagus and cell type to the squamous cell carcinoma. Follow-up was completed in 100 patients (9 4%) and ranged from 1 month to 92 months (median; 6 months). RESULTS: The median age was 62 years old and male to female ratio was 104:2. Fifty-three percent was the middle thorax lesion and curative radiotherapy was performed in 83%. Mean tumor dose delivered with curative aim was 58.6 Gy (55-70.8 Gy) and median duration o f the radiation therapy was 53 days. The median survival of all patients was 6 months and 1-year and 2-year overall survival rte was 27% and 12%, respectively. Improvement of dysphagia was obtained in most patients except fo 7 patients who underwent feeding gastrostomy. The complete response rate immediately after radiation therapy was 32% (34/106). The median survival and 2-year survival rate of the complete responder was 14 months and 30% respectively, while those of the nonresponder was 4 months and 0% respectively (p=0.000). The median survival and 2-year survival rate of the patients who could tolerate regular diet was 9 rnonths and 16% while those of the patients who could not tolerate regular diet was 3 months and 0%, respectively (p=0.004). The survival difference between the patients with 5 cm or less turnor length and those with more than 5 cm tumor length was rnarginally statistically significant (p=0.06). However, the survival difference according to the periesophageal invasion or mediastinal lymphadenopathy in the chest CT imaging study was not statistically significant in this study. In a multivariate analysis, the statistically significant covariates to the survival were complete response to radiotherapy, tumor length, and initial degree of dysphagia in a decreasing order. The complication was observed in 10 patients (9%). CONCLUSION: The survival outcome for advanced esophageal cancer patients treated by external be am radiotherapy alone was very poor, In the treatment of these patients, the brachytherapy and chemotherapy should be added to improve the treatment outcome.
